HC 1344 Limited 14804693 false 2023-04-15 2024-04-30 2024-04-30 The principal activity of the company is that of a holding company. Digita Accounts Production Advanced 6.30.9574.0 true true false false 14804693 2023-04-15 2024-04-30 14804693 2024-04-30 14804693 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-04-30 14804693 core:CurrentFinancialInstruments 2024-04-30 14804693 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 14804693 core:AdditionsToInvestments 2024-04-30 14804693 bus:SmallEntities 2023-04-15 2024-04-30 14804693 bus:AuditExemptWithAccountantsReport 2023-04-15 2024-04-30 14804693 bus:FullAccounts 2023-04-15 2024-04-30 14804693 bus:SmallCompaniesRegimeForAccounts 2023-04-15 2024-04-30 14804693 bus:RegisteredOffice 2023-04-15 2024-04-30 14804693 bus:Director1 2023-04-15 2024-04-30 14804693 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-04-15 2024-04-30 14804693 bus:PrivateLimitedCompanyLtd 2023-04-15 2024-04-30 14804693 core:Subsidiary1 2023-04-15 2024-04-30 14804693 core:Subsidiary1 1 2023-04-15 2024-04-30 14804693 countries:EnglandWales 2023-04-15 2024-04-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 14804693

Prepared for the registrar

HC 1344 Limited

Annual Report and Unaudited Financial Statements

for the Period from 15 April 2023 to 30 April 2024

 

HC 1344 Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 5

 

HC 1344 Limited

Company Information

Director

B N G Craig

Registered office

Eagle Tower
Montpellier Drive
Cheltenham
Gloucestershire
GL50 1TA

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

HC 1344 Limited

(Registration number: 14804693)
Balance Sheet as at 30 April 2024

Note

2024
£

Fixed assets

 

Investments

4

2,152,203

Current assets

 

Debtors

5

1

Creditors: Amounts falling due within one year

6

(2,152,203)

Net current liabilities

 

(2,152,202)

Net assets

 

1

Capital and reserves

 

Called up share capital

1

Shareholders' funds

 

1

For the financial period ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 13 January 2025
 


B N G Craig
Director

 

HC 1344 Limited

Notes to the Unaudited Financial Statements for the Period from 15 April 2023 to 30 April 2024

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Eagle Tower
Montpellier Drive
Cheltenham
Gloucestershire
GL50 1TA

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

 

HC 1344 Limited

Notes to the Unaudited Financial Statements for the Period from 15 April 2023 to 30 April 2024

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

 

HC 1344 Limited

Notes to the Unaudited Financial Statements for the Period from 15 April 2023 to 30 April 2024

 

4

Investments

2024
£

Investments in subsidiaries

2,152,203

Subsidiaries

£

Cost

Additions

2,152,203

Carrying amount

At 30 April 2024

2,152,203

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Country of incorporation

Holding

Proportion of voting rights and shares held

     

2024

Subsidiary undertakings

Infosec People Limited

United Kingdom

810 Ordinary shares

100%

 

5

Debtors

30 April 2024
 £

Other debtors

1

 

6

Creditors

30 April 2024
 £

Due within one year

Amounts due to related parties

462,501

Other creditors

1,689,702

2,152,203

 

7

Share capital

Allotted, called up and fully paid shares

 

30 April 2024

 

No.

£

Ordinary share of £1 each

1

1